Improvement of asthma control in adult patients using extrafine inhaled beclomethasone/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy – CONTROL study
Open Access
- 28 November 2023
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 84, 102272
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view.Pulmonary Pharmacology & Therapeutics, 2014
- Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthmaRespiratory Medicine, 2013
- Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trialThe Lancet Respiratory Medicine, 2013
- Doctor–patient relationship: A resource to improve respiratory diseases managementEuropean Journal of Internal Medicine, 2012
- Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking statusRespiratory Medicine, 2012
- The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma controlPrimary Care Respiratory Journal, 2009
- Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adultsRespiratory Medicine, 2007
- Measurement properties and interpretation of three shortened versions of the asthma control questionnaireRespiratory Medicine, 2005
- Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthmaThorax, 2002
- Compliance in asthmaRespiratory Medicine, 1999